Effects of endocrine disruptors in the development of the female reproductive tract;Efeitos dos desreguladores endócrinos no desenvolvimento do trato reprodutivo feminino

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 58, Issue 2, 2014, Pages 153-161

  Costa, Elaine Maria Frade ^a   Spritzer, Poli Mara ^b   Hohl, Alexandre ^c   Bachega, Tânia A S S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Endocrine disruptors; Female development; Polycystic ovary syndrome; Precocious puberty; Premature ovarian failure

Indexed keywords

DIOXIN; ENDOCRINE DISRUPTOR; PESTICIDE;

ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DISORDER OF SEX DEVELOPMENT; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MOUSE; OVARY DISEASE; PRECOCIOUS PUBERTY; PREGNANCY;

ANIMALS; DIOXINS; DISORDERS OF SEX DEVELOPMENT; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MICE; OVARIAN DISEASES; PESTICIDES; PREGNANCY; PUBERTY, PRECOCIOUS;

EID: 84900536765     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/0004-2730000003031     Document Type: Article

References (49)

1. Bachega TASS, Verreschi IT, Frade EMC, D'Abronzo FH, Lazaretti- Castro M. The environmental endocrine disruptors must receive the attention of Brazilian endocrinologists. Arq Bras Endocrinol Metab. 2011;55(2):175-6.
2. Decherf S, Demeneix BA. The obesogen hypothesis: a shift of focus from the periphery to the hypothalamus. J Toxicol Environ Health B Crit Rev. 2011;14(5-7):423-48.
3. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011;127(3-5):204-15.
4. Christensen BC, Marsit CJ. Epigenomics in environmental health. Front Genet. 2011;2:84.
5. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342.
6. Zoeller RT. Endocrine disruptors: do family lines carry an epigenetic record of previous generations' exposures? Endocrinology. 2006;147(12):5513-4.
7. Hao C, Cheng X, Xia H, Ma X. The endocrine disruptor mono- (2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice. Biosci Rep. 2012;32(6): 619-29.
8. Chang JW, Chen HL, Su HJ, Liao PC, Guo HR, Lee CC. Dioxin exposure and insulin resistance in Taiwanese living near a highly contaminated area. Epidemiology. 2010;21(1):56-61.
9. Liem AK, Fürst P, Rappe C. Exposure of populations to dioxins and related compounds. Food Addit Contam. 2000;17(4):241-59.
10. Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol. 2011;73:135-62.
11. Hayes TB, Anderson LL, Beasley VR, de Solla SR, Iguchi T, Ingraham H, et al. Demasculinization and feminization of male gonads by atrazine: consistent effects across vertebrate classes. J Steroid Biochem Mol Biol. 2011;127(1-2):64-73.
12. Bigsby R, Chapin RE, Daston GP, Davis BJ, Gorski J, Gray LE, et al. Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect. 1999;107(4):613-8.
13. Fortes EM, Malerba MI, Luchini PD, Sugawara EK, Sumodjo L, Ribeiro Neto LM, et al. [High intake of phytoestrogens and precocious thelarche: case report with a possible correlation]. Arq Bras Endocrinol Metab. 2007;51(3):500-3.
14. Buttke DE, Sircar K, Martin C, et al. Exposures to endocrinedisrupting chemicals and age of menarche in adolescent girls in NHANES (2003-2008). Environ Health Perspect. 2012;120:1613-8.
15. Patisaul HB. Effects of environmental endocrine disruptors and phytoestrogens on the kisspeptin system. Adv Exp Med Biol. 2013;784:455-79.
16. Mouritsen A, Aksglaede L, Sørensen K, Mogensen SS, Leffers H, Main KM, et al. Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl. 2010;33:346-59.
17. Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect. 1994;102(8):680-8.
18. Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voigt RC, et al. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol. 2003;13(7):546-53.
19. Eichenlaub-Ritter U, Vogt E, Cukurcam S, Sun F, Pacchierotti F, Parry J. Exposure of mouse oocytes to bisphenol A causes meiotic arrest but not aneuploidy. Mutat Res. 2008;651(1-2):82-92.
20. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606-14.
21. Cooper AR, Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson LM. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2011;95(6):1890-7.
22. Kirigaya A, Kim H, Hayashi S, Chambon P, Watanabe H, Lguchi T, et al. Involvement of estrogen receptor beta in the induction of polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol. Zoolog Sci. 2009;26(10):704-12.
23. Newbold RR, Jefferson WN, Padilla-Banks E. Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect. 2009;117(6):879-85.
24. Brieño-Enríquez MA, Reig-Viader R, Cabero L, Toran N, Martínez F, Roig I, et al. Gene expression is altered after bisphenol A exposure in human fetal oocytes in vitro. Mol Hum Reprod. 2012;18(4):171-83.
25. Ahn HJ, An BS, Jung EM, Yang H, Choi KC, Jeung EB. Parabens inhibit the early phase of folliculogenesis and steroidogenesis in the ovaries of neonatal rats. Mol Reprod Dev. 2012;79(9):626-36.
26. Hoyer PB, Devine PJ, Hu X, Thompson KE, Sipes IG. Ovarian toxicity of 4-vinylcyclohexene diepoxide: a mechanistic model. Toxicol Pathol. 2001;29(1):91-9.
27. Kappeler CJ, Hoyer PB. 4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity. Syst Biol Reprod Med. 2012;58(1):57-62.
28. Cummings AM. Methoxychlor as a model for environmental estrogens. Crit Rev Toxicol. 1997;27(4):367-79.
29. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol. 2000;58(4):852-8.
30. Martinez EM, Swartz WJ. Effects of methoxychlor on the reproductive system of the adult female mouse. Gross and histologic observations. Reprod Toxicol. 1991;5(2):139-47.
31. Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199(2):142-50.
32. Chao HR, Wang SL, Lin LY, Lee WJ, Papke O. Placental transfer of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in Taiwanese mothers in relation to menstrual cycle characteristics. Food Chem Toxicol. 2007;45(2):259-65.
33. Axmon A, Rylander L, Strömberg U, Hagmar L. Altered menstrual cycles in women with a high dietary intake of persistent organochlorine compounds. Chemosphere. 2004;56(8):813-9.
34. Farr SL, Cooper GS, Cai J, Savitz DA, Sandler DP. Pesticide use and menstrual cycle characteristics among premenopausal women in the Agricultural Health Study. Am J Epidemiol. 2004;160(12):1194-204.
35. Nikaido Y, Yoshizawa K, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol. 2004;18(6):803-11.
36. Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, Ronsheim PM, Soto AM. Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology. 2006;147(8):3681-91.
37. Bastos AM, de Souza Mdo C, de Almeida Filho GL, Krauss TM, Pavesi T, da Silva LE. Organochlorine compound levels in fertile and infertile women from Rio de Janeiro, Brazil. Arq Bras Endocrinol Metabol. 2013;57(5):346-53.
38. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004;51:165-9.
39. Zhou W, Liu J, Liao L, Han S, Liu J. Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol. 2008;283:12-8.
40. Hanioka N, Jinno H, Nishimura T, Ando M. Suppression of malespecific cytochrome P450 isoforms by bisphenol A in rat liver. Arch Toxicol. 1998;72:387-94.
41. Fernández M, Bourguignon N, Lux-Lantos V, Libertun C. Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect. 2010;118:1217-22.
42. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect. 2006;114:106-12.
43. Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou F, Koutsilieris M, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab. 2011;96:E480-4.
44. Pasquali R, Stener-Victorin E, Yildiz BO, Duleba AJ, Hoeger K, Mason H, et al. PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf). 2011;74:424-33.
45. Uribarri J, Tuttle KR. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol. 2006;1:1293-9.
46. Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, et al. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008;69:634-41.
47. Jinno M, Takeuchi M, Watanabe A, Teruya K, Hirohama J, Eguchi N, et al. Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum Reprod. 2011;26:604-10.
48. Diamanti-Kandarakis E, Piouka A, Livadas S, Piperi C, Katsikis I, Papavassiliou AG, et al. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol. 2009;160:847-53.
49. Costa EMF, et al. Desreguladores Endócrinos. In: Proendócrino. vol. 4. Porto Alegre: Artmed Panamericana; 2013.